Increases Full Year 2021 Earnings Guidance
|
Quarter ended |
||
|
2021 |
|
2020 |
|
|
|
|
(In millions, except per-share results) |
|
||
Premium Revenue |
|
|
|
Total Revenue |
|
|
|
|
|
|
|
GAAP: |
|
|
|
Net Income |
|
|
|
EPS – Diluted |
|
|
|
Medical Care Ratio (MCR) |
86.8% |
|
86.3% |
G&A Ratio |
7.3% |
|
7.0% |
After-tax Margin |
3.5% |
|
3.9% |
|
|
|
|
Adjusted: |
|
|
|
Net Income |
|
|
|
EPS – Diluted |
|
|
|
G&A Ratio |
7.0% |
|
7.0% |
After-tax Margin |
4.0% |
|
4.0% |
See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release. |
|||
Quarter Highlights
-
GAAP net income for the first quarter of 2021 was
$3.89 per diluted share, a 33% increase over the first quarter of 2020. -
Adjusted net income for the first quarter of 2021 was
$4.44 per diluted share, a 47% increase over the first quarter of 2020. -
As of
March 31, 2021 , the Company served approximately 4.6 million members, an increase of 1.2 million members, or 35%, compared toMarch 31, 2020 . -
Premium revenue was
$6.3 billion for the first quarter of 2021, an increase of 47% compared to the first quarter of 2020. -
The Company increased its full year 2021 premium revenue guidance to more than
$24.0 billion , from its previous guidance of more than$23.0 billion . -
The Company increased its full year 2021 adjusted earnings guidance to no less than
$13.00 per diluted share, from its previous range of$12.50 -$13.00 per diluted share.
“We are very pleased with our first quarter performance as we continue to demonstrate our ability to produce excellent financial results while substantially growing top line revenue and managing through the ongoing impacts of the pandemic,” said
Ohio Procurement
On
Texas Acquisition
On
Total Revenue
Total revenue was
Net Income
Net income for the first quarter was
The Company estimates the net effect of COVID had a negligible impact in the first quarter of 2021, as utilization curtailment was offset by COVID-related risk corridors and direct COVID medical costs.
Medical Care Ratio
The consolidated MCR for the first quarter was 86.8%, compared to 86.3% for the first quarter of 2020. While the net effect of COVID was in line with the Company’s expectations and negligible to the quarter in total, the impacts were varied across lines of business.
- Medicaid MCR: Decreased to 87.5%, compared to 88.9% for the first quarter of 2020. The MCR was positively impacted by the net effect of COVID. Lower utilization due to COVID curtailment, severe winter weather in several states, and the absence of a typical flu season, more than offset the impact of the various COVID-related risk corridors enacted in several states as previously disclosed.
- Medicare MCR: Increased to 90.3%, compared to 81.7% for the first quarter of 2020. The MCR was negatively impacted by the net effect of COVID and the temporary industry-wide challenge of risk scores that do not fully reflect the acuity of the membership.
- Marketplace MCR: Increased to 77.3%, compared to 72.3% for the first quarter of 2020. The MCR was negatively impacted by the net effect of COVID compared to the pre-pandemic first quarter of 2020.
The prior year reserve development in the first quarter of 2021 was modestly favorable, but its impact on earnings was absorbed by the COVID-related risk corridors.
General and Administrative Expense Ratio
The G&A ratio for the first quarter was 7.3%, compared to 7.0% for the first quarter of 2020. The adjusted G&A ratio for the first quarter was 7.0%, which was unchanged compared to the first quarter of 2020.
Balance Sheet
Cash and investments at the parent company amounted to
Cash Flow
Operating cash flow for the first quarter of 2021 amounted to
2021 Guidance
The Company now expects its full year 2021 premium revenue to be more than
The Company increased its full year 2021 adjusted earnings per share guidance to be no less than
Revised guidance reflects:
- The impact of the Public Health Emergency period, and the associated pause on Medicaid membership redeterminations, which is now expected to continue through the third quarter of 2021;
- Strong membership pickup in the Marketplace open enrollment coupled with slower membership attrition during the quarter; and,
- The Company continues to be cautious in forecasting utilization trends in the remaining nine months of the year due to COVID pandemic.
The impact of the Affinity and the Cigna Texas membership acquisitions are not included.
See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.
Conference Call
Management will host a conference call and webcast to discuss Molina Healthcare’s first quarter 2021 results at
About
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This earnings release and the Company’s accompanying oral remarks contain forward-looking statements regarding its 2021 guidance, as well as its plans, expectations, and the Company’s expectations regarding future developments. Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended
These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of
|
|||||||
|
|||||||
|
Three Months Ended |
||||||
|
|
||||||
|
2021 |
|
2020 |
||||
|
|
|
|
||||
|
(In millions, except per-share amounts) |
||||||
Revenue: |
|
|
|
||||
Premium revenue |
$ |
6,306 |
|
|
$ |
4,304 |
|
Premium tax revenue |
187 |
|
|
150 |
|
||
Health insurer fees reimbursed |
— |
|
|
66 |
|
||
Investment income |
9 |
|
|
25 |
|
||
Other revenue |
20 |
|
|
4 |
|
||
Total revenue |
6,522 |
|
|
4,549 |
|
||
Operating expenses: |
|
|
|
||||
Medical care costs |
5,474 |
|
|
3,716 |
|
||
General and administrative expenses |
473 |
|
|
317 |
|
||
Premium tax expenses |
187 |
|
|
150 |
|
||
Health insurer fees |
— |
|
|
68 |
|
||
Depreciation and amortization |
33 |
|
|
20 |
|
||
Other |
20 |
|
|
4 |
|
||
Total operating expenses |
6,187 |
|
|
4,275 |
|
||
Operating income |
335 |
|
|
274 |
|
||
Other expenses, net: |
|
|
|
||||
Interest expense |
30 |
|
|
21 |
|
||
Total other expenses, net |
30 |
|
|
21 |
|
||
Income before income tax expense |
305 |
|
|
253 |
|
||
Income tax expense |
77 |
|
|
75 |
|
||
Net income |
$ |
228 |
|
|
$ |
178 |
|
|
|
|
|
||||
Net income per share – Diluted |
$ |
3.89 |
|
|
$ |
2.92 |
|
|
|
|
|
||||
Diluted weighted average shares outstanding |
58.6 |
|
|
61.0 |
|
||
|
|
|
|
||||
Operating Statistics: |
|
|
|
||||
Medical care ratio |
86.8 |
% |
|
86.3 |
% |
||
G&A ratio |
7.3 |
% |
|
7.0 |
% |
||
Premium tax ratio |
2.9 |
% |
|
3.4 |
% |
||
Effective income tax rate |
25.2 |
% |
|
29.8 |
% |
||
After-tax margin |
3.5 |
% |
|
3.9 |
% |
|
|||||||
|
|||||||
|
|
|
|
||||
|
2021 |
|
2020 |
||||
|
Unaudited |
|
|
||||
|
(Dollars in millions, except per-share amounts) |
||||||
ASSETS |
|||||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
4,431 |
|
|
$ |
4,154 |
|
Investments |
1,938 |
|
|
1,875 |
|
||
Receivables |
1,776 |
|
|
1,672 |
|
||
Prepaid expenses and other current assets |
163 |
|
|
175 |
|
||
Total current assets |
8,308 |
|
|
7,876 |
|
||
Property, equipment, and capitalized software, net |
378 |
|
|
391 |
|
||
|
923 |
|
|
941 |
|
||
Restricted investments |
138 |
|
|
136 |
|
||
Deferred income taxes |
66 |
|
|
69 |
|
||
Other assets |
137 |
|
|
119 |
|
||
Total assets |
$ |
9,950 |
|
|
$ |
9,532 |
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|||||||
Current liabilities: |
|
|
|
||||
Medical claims and benefits payable |
$ |
2,839 |
|
|
$ |
2,696 |
|
Amounts due government agencies |
1,718 |
|
|
1,253 |
|
||
Accounts payable, accrued liabilities and other |
695 |
|
|
641 |
|
||
Deferred revenue |
71 |
|
|
375 |
|
||
Total current liabilities |
5,323 |
|
|
4,965 |
|
||
Long-term debt |
2,128 |
|
|
2,127 |
|
||
Finance lease liabilities |
223 |
|
|
225 |
|
||
Other long-term liabilities |
112 |
|
|
119 |
|
||
Total liabilities |
7,786 |
|
|
7,436 |
|
||
Stockholders’ equity: |
|
|
|
||||
Common stock, |
— |
|
|
— |
|
||
Preferred stock, |
— |
|
|
— |
|
||
Additional paid-in capital |
170 |
|
|
199 |
|
||
Accumulated other comprehensive income |
26 |
|
|
37 |
|
||
Retained earnings |
1,968 |
|
|
1,860 |
|
||
Total stockholders’ equity |
2,164 |
|
|
2,096 |
|
||
Total liabilities and stockholders’ equity |
$ |
9,950 |
|
|
$ |
9,532 |
|
|
|||||||
|
|||||||
|
Three Months Ended |
||||||
|
|
||||||
|
2021 |
|
2020 |
||||
|
|
|
|
||||
|
(in millions) |
||||||
Operating activities: |
|
|
|
||||
Net income |
$ |
228 |
|
|
$ |
178 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
33 |
|
|
20 |
|
||
Deferred income taxes |
6 |
|
|
14 |
|
||
Share-based compensation |
24 |
|
|
12 |
|
||
Other, net |
12 |
|
|
(3 |
) |
||
Changes in operating assets and liabilities: |
|
|
|
||||
Receivables |
(98 |
) |
|
(197 |
) |
||
Prepaid expenses and other current assets |
(15 |
) |
|
(229 |
) |
||
Medical claims and benefits payable |
168 |
|
|
127 |
|
||
Amounts due government agencies |
432 |
|
|
113 |
|
||
Accounts payable, accrued liabilities and other |
16 |
|
|
254 |
|
||
Deferred revenue |
(304 |
) |
|
(206 |
) |
||
Income taxes |
66 |
|
|
60 |
|
||
Net cash provided by operating activities |
568 |
|
|
143 |
|
||
Investing activities: |
|
|
|
||||
Purchases of investments |
(388 |
) |
|
(578 |
) |
||
Proceeds from sales and maturities of investments |
308 |
|
|
493 |
|
||
Purchases of property, equipment, and capitalized software |
(16 |
) |
|
(21 |
) |
||
Other, net |
9 |
|
|
3 |
|
||
Net cash used in investing activities |
(87 |
) |
|
(103 |
) |
||
Financing activities: |
|
|
|
||||
Common stock purchases |
(128 |
) |
|
(453 |
) |
||
Common stock withheld to settle employee tax obligations |
(51 |
) |
|
(7 |
) |
||
Contingent consideration liabilities settled |
(20 |
) |
|
— |
|
||
Proceeds from borrowings under term loan facility |
— |
|
|
380 |
|
||
Other, net |
(8 |
) |
|
(45 |
) |
||
Net cash used in financing activities |
(207 |
) |
|
(125 |
) |
||
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents |
274 |
|
|
(85 |
) |
||
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period |
4,223 |
|
|
2,508 |
|
||
Cash, cash equivalents, and restricted cash and cash equivalents at end of period |
$ |
4,497 |
|
|
$ |
2,423 |
|
|
|||||||||
|
|||||||||
|
|
|
|
|
|
||||
|
2021 (1) |
|
2020 |
|
2020 |
||||
Ending Membership by Segment: |
|
|
|
|
|
||||
Medicaid |
3,859,000 |
|
|
3,599,000 |
|
|
2,970,000 |
|
|
Medicare |
126,000 |
|
|
115,000 |
|
|
105,000 |
|
|
Marketplace |
620,000 |
|
|
318,000 |
|
|
329,000 |
|
|
Total |
4,605,000 |
|
|
4,032,000 |
|
|
3,404,000 |
|
|
__________________________
|
|
Three Months Ended |
||||||||||||||||||||
|
2021 |
|
2020 |
||||||||||||||||||
|
Premium Revenue |
|
Medical Care Costs |
|
MCR (1) |
|
Premium Revenue |
|
Medical Care Costs |
|
MCR (1) |
||||||||||
|
|
|
|
|
|
||||||||||||||||
Medicaid |
$ |
4,840 |
|
|
$ |
4,236 |
|
|
87.5 |
% |
|
$ |
3,286 |
|
|
$ |
2,921 |
|
|
88.9 |
% |
Medicare |
799 |
|
|
722 |
|
|
90.3 |
|
|
634 |
|
|
517 |
|
|
81.7 |
|
||||
Marketplace |
667 |
|
|
516 |
|
|
77.3 |
|
|
384 |
|
|
278 |
|
|
72.3 |
|
||||
Consolidated |
$ |
6,306 |
|
|
$ |
5,474 |
|
|
86.8 |
% |
|
$ |
4,304 |
|
|
$ |
3,716 |
|
|
86.3 |
% |
__________________________
|
|||||||||||||||||||||
CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)
The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:
|
Three Months Ended |
||||||
|
|
||||||
|
2021 |
|
2020 |
||||
|
|
|
|
||||
|
Unaudited |
||||||
Medical claims and benefits payable, beginning balance |
$ |
2,696 |
|
|
$ |
1,854 |
|
Components of medical care costs related to: |
|
|
|
||||
Current year |
5,668 |
|
|
3,817 |
|
||
Prior year |
(194 |
) |
|
(101 |
) |
||
Total medical care costs |
5,474 |
|
|
3,716 |
|
||
Payments for medical care costs related to: |
|
|
|
||||
Current year |
3,513 |
|
|
2,274 |
|
||
Prior year |
1,781 |
|
|
1,305 |
|
||
Total paid |
5,294 |
|
|
3,579 |
|
||
Change in acquired balances |
(25 |
) |
|
— |
|
||
Change in non-risk and other provider payables |
(12 |
) |
|
(10 |
) |
||
Medical claims and benefits payable, ending balance |
$ |
2,839 |
|
|
$ |
1,981 |
|
|
|
|
|
||||
Days in claims payable, fee for service (1) |
48 |
|
|
49 |
|
||
__________________________
|
|||||||
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES
(In millions, except per diluted share amounts)
The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.
Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.
Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.
Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.
Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.
Adjusted after-tax margin represents adjusted net income, divided by total revenue.
|
Three Months Ended |
||||||||||||||
2021 |
|
2020 |
|||||||||||||
|
Amount |
|
Per Diluted Share |
|
Amount |
|
Per Diluted Share |
||||||||
Net income |
$ |
228 |
|
|
$ |
3.89 |
|
|
$ |
178 |
|
|
$ |
2.92 |
|
Adjustments: |
|
|
|
|
|
|
|
||||||||
Acquisition-related expenses (1) |
21 |
|
|
0.36 |
|
|
— |
|
|
— |
|
||||
Amortization of intangible assets |
12 |
|
|
0.21 |
|
|
4 |
|
|
0.06 |
|
||||
Other (2) |
9 |
|
|
0.15 |
|
|
4 |
|
|
0.07 |
|
||||
Subtotal, adjustments |
42 |
|
|
0.72 |
|
|
8 |
|
|
0.13 |
|
||||
Income tax effect |
(10 |
) |
|
(0.17 |
) |
|
(2 |
) |
|
(0.03 |
) |
||||
Adjustments, net of tax |
32 |
|
|
0.55 |
|
|
6 |
|
|
0.10 |
|
||||
Adjusted net income |
$ |
260 |
|
|
$ |
4.44 |
|
|
$ |
184 |
|
|
$ |
3.02 |
|
__________________________
|
|||||||||||||||
(2) The first quarter of 2021 includes change in premium deficiency reserves, loss on sale of property, and restructuring costs. The first quarter of 2020 includes restructuring costs. |
|
|||
Net income per diluted share (1) |
$ |
11.45 |
|
Adjustments: |
|
||
Acquisition-related expenses |
1.10 |
|
|
Amortization of intangible assets |
0.79 |
|
|
Other |
0.15 |
|
|
Subtotal, adjustments |
2.04 |
|
|
Income tax effect (2) |
(0.49 |
) |
|
Adjustments, net of tax |
1.55 |
|
|
Adjusted net income per diluted share |
$ |
13.00 |
|
__________________________
|
|||
(2) Income tax effect calculated at the statutory tax rate of 23.9%. |
|||
View source version on businesswire.com: https://www.businesswire.com/news/home/20210428006013/en/
Investor Contact:
Media Contact:
Source: